FDA Drug recall D-296-2013
Pantoprazole Sodium Delayed Release Tablets USP, 40 mg, 90 count bottles, Manufactured by Jubilant Life Sciences Ltd, Roorkee-247661 India…
- FDA Drug
- Class II
- terminated
- Published 2013-05-08
On 2013-05-08 the FDA classified a Class II recall of Pantoprazole Sodium Delayed Release Tablets USP, 40 mg, 90 count bottles, Manufactured by Jubilant Life Sciences Ltd, Roorkee-247661 India… by Jubilant Cadista Pharmaceuticals, citing cGMP Deviations: Oral products were not manufactured in accordance with Good Manufacturing Practices.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-296-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-02-11 |
| Published | 2013-05-08 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Jubilant Cadista Pharmaceuticals |
| Distribution | US |
Product
Pantoprazole Sodium Delayed Release Tablets USP, 40 mg, 90 count bottles, Manufactured by Jubilant Life Sciences Ltd, Roorkee-247661 India ;Marketed by Jubilant Cadista Pharmaceuatical Inc Salisbury, MD 21801 NDC 59746-284-90
Reason
cGMP Deviations: Oral products were not manufactured in accordance with Good Manufacturing Practices.
Identifiers
| code_info | Lot PA22028 Exp 5/2014 Lot PA22029 Exp 5/2014 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-296-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.